Michael Brooks
2021
In 2021, Michael Brooks earned a total compensation of $1.1M as President at Edesa Biotech, a 99% increase compared to previous year.
Compensation breakdown
| Bonus | $110,000 |
|---|---|
| Option Awards | $605,857 |
| Salary | $293,750 |
| Other | $42,339 |
| Total | $1,051,946 |
Brooks received $605.9K in option awards, accounting for 58% of the total pay in 2021.
Brooks also received $110K in bonus, $293.8K in salary and $42.3K in other compensation.
Rankings
In 2021, Michael Brooks' compensation ranked 8,634th out of 12,415 executives tracked by ExecPay. In other words, Brooks earned more than 30.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,634 out of 12,415 | 31st |
Division Manufacturing | 3,828 out of 5,501 | 30th |
Major group Chemicals And Allied Products | 1,693 out of 2,371 | 29th |
Industry group Drugs | 1,506 out of 2,092 | 28th |
Industry Pharmaceutical Preparations | 1,122 out of 1,542 | 27th |
Source: SEC filing on April 1, 2022.
Brooks' colleagues
We found two more compensation records of executives who worked with Michael Brooks at Edesa Biotech in 2021.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020